NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that Nacalai USA will distribute TriLink's nucleic acid products in certain Asian countries.
Under the agreement, Nacalai will distribute TriLink's technologies in Japan, Singapore, South Korea, and Taiwan.
TriLink's product offerings include custom oligonucleotides, modified nucleoside triphosphates, and its CleanAmp PCR products for the diagnostic and OEM markets.
Nacalai USA is the San Diego-based subsidiary of Nacalai Tesque, of Kyoto, Japan.
The company said that the agreement will give the Asian market access to modified nucleic acid products to further advance research efforts in areas such as molecular biology and proteomics.